Key result
Prior CABG is linked to ~3-fold higher 5-year target vessel revascularization after PCI.
Why the study?
Does a history of previous coronary artery bypass grafting impact 5-year clinical outcomes (such as cardiac death and target vessel revascularization) in patients undergoing PCI with newer-generation drug-eluting stents for stable angina or NSTE-ACS?
Cohort (n=1,709)
No
Does a history of previous coronary artery bypass grafting impact 5-year clinical outcomes (such as cardiac death and target vessel revascularization) in patients undergoing PCI with newer-generation drug-eluting stents for stable angina or NSTE-ACS?
Despite low stent thrombosis rates with newer-generation DES, patients with prior CABG remain at substantially higher 5-year risk for cardiac death and target vessel revascularization, particularly when saphenous vein grafts are stented, supporting a native-vessel-first PCI strategy.
Answers are grounded in this paper and cite their sources.
Prior CABG marks higher-risk PCI patients; extends observational data on contemporary stents but leaves optimal strategies open for trials.
Background Percutaneous coronary intervention ( PCI ) in patients with previous coronary artery bypass grafting ( CABG ) is associated with adverse clinical events. Although newer generation drug‐eluting stents showed favorable short‐term safety profiles, there is a lack of long‐term outcome data. We evaluated the impact of previous CABG on 5‐year clinical outcomes of patients treated with PCI using newer‐generation drug‐eluting stents. Methods and Results In this patient‐level pooled analysis of the prospective TWENTE (The Real‐World Endeavor Resolute versus Xience V Drug‐Eluting Stent Study in Twente) trial and nonenrolled TWENTE registry, we assessed a consecutive series of patients who underwent PCI with newer‐generation drug‐eluting stents for non– ST ‐segment–elevation acute coronary syndromes or stable angina. Of all 1709 patients, 202 (11.8%) had a history of CABG . Patients with previous CABG had significantly higher 5‐year rates of cardiac death (10.4% versus 4.3%; P <0.001) and target vessel revascularization (25.0% versus 8.1%; P <0.001). These differences remained statistically significant after adjustment for differences in baseline characteristics. Landmark analysis revealed that from 1‐ to 5‐year follow‐up, the rates of cardiac death (8.1% versus 3.2%; P <0.001) and target vessel revascularization (17.1% versus 5.9%; P <0.001) were significantly higher in patients with previous CABG . Among patients with a history of CABG , PCI of an obstructed vein graft was associated with a higher rate of 5‐year target vessel revascularization ( P =0.003). Conclusions At 5‐year follow‐up after PCI with newer‐generation drug‐eluting stents, the risk of cardiac death and target vessel revascularization was significantly higher in patients with previous CABG . The target vessel revascularization rate was highest in patients who underwent PCI of obstructed vein grafts.
No takes yet. Share an insight, caveat, or question.
Heijden et al. (2018) conducted a cohort in Patients undergoing PCI with newer-generation drug-eluting stents for NSTE-ACS or stable angina (n=1,709). Previous coronary artery bypass grafting (CABG) vs. No previous CABG was evaluated on 5-year target vessel revascularization (Adjusted HR 3.00, 95% CI 2.01-4.46, p=<0.001). Previous CABG was associated with higher 5-year rates of target vessel revascularization and cardiac death after PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: